Epidemiological, Pathological and Histomolecular Phenotyping Patterns of Female Breast Cancer: A Single Center Study in Al-Madinah City of Saudi Arabia
This single-center retrospective study of 284 women in Al-Madinah, Saudi Arabia, reveals that while Luminal A is the predominant breast cancer subtype, a significant proportion of patients present with late-stage disease and distant metastasis, highlighting a gap between national screening efforts and early detection outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer is a disease that affects the cells of the breast, turning them into a mass that grows and spreads if not stopped. While it is the most common cancer found in women around the world, the way it behaves can change depending on where a person lives and how old they are. In some places, doctors find it in older women, while in others, it strikes younger women. To understand how to treat it, scientists look at the specific "fingerprint" of the tumor. They check if the cancer cells have certain proteins on their surface that act like keys, allowing them to grow when triggered by hormones or other signals. Knowing which keys a tumor has helps doctors choose the right medicine to lock those doors and stop the cancer. This knowledge is especially important in Saudi Arabia, where the disease is a major health concern, yet details about how it appears in different groups of women have been harder to find.
A researcher in the city of Al-Madinah decided to fill this gap by looking closely at the records of women treated for breast cancer between 2018 and 2020. They gathered information on 284 women, both Saudi citizens and foreign residents living in the region, to see what the tumors looked like and how they were distributed. The study focused on three main things: the age of the women when they were diagnosed, the size and spread of the tumors, and the specific molecular type of the cancer. By examining these details, the researcher hoped to paint a clear picture of the disease in their local community and see if the patterns were changing over those three years.
The average woman in this group was 51 years old, and the vast majority were over 40. Most of the women were Saudi nationals. When the doctors looked at the tumors, they found that the most common type was an invasive ductal carcinoma, which accounts for more than 90 percent of the cases. This is a cancer that starts in the milk ducts and grows into the surrounding tissue. In terms of how far the cancer had spread, the most frequent finding was stage two, where the tumor is still relatively contained but has begun to grow larger. However, a significant number of women, nearly a quarter, already had cancer that had traveled to distant parts of their bodies, such as the lungs or bones, by the time they were diagnosed. This is a serious finding because it means the disease was advanced before it was caught.
When the researcher sorted the tumors by their molecular fingerprints, they found a clear pattern. The most common type was called Luminal A, which makes up about half of all cases. These tumors have receptors for hormones but do not have a specific protein called HER2, which usually makes them grow faster. The next most common group was the triple-negative type, which lacks all the common receptors and is often harder to treat. The remaining cases were split between tumors that had the HER2 protein and those that had both hormone receptors and HER2. Interestingly, the mix of these types did not change much from 2018 to 2020, suggesting a stable pattern in the region.
The study also looked at whether the age of the patient changed the type of cancer they had. They found that younger women were more likely to have triple-negative tumors, while older women were much more likely to have the Luminal A type. This difference is important because it suggests that the biology of the disease shifts as women get older. Despite national campaigns to encourage early screening that began in 2015, the study showed that many women were still being diagnosed at later stages. In fact, the number of women diagnosed with very large tumors or cancer that had spread to distant organs seemed to rise slightly in 2020. The researcher noted that this might be linked to the disruptions caused by the global pandemic, which may have made people delay their checkups or screenings due to fear of infection or lockdowns.
One of the key takeaways from this work is that while the types of breast cancer in Al-Madinah are similar to what is seen in other parts of Saudi Arabia, the disease is still being found too late in many cases. The researcher pointed out that they could not analyze a specific marker called Ki-67 for most patients because the data was missing, which is a limitation of their study. They also noted that because they only looked at one hospital, the results might not perfectly represent every woman in the country. Nevertheless, the study provides a solid snapshot of the current situation. It confirms that breast cancer in this region affects a wide range of ages but hits the older population most often, and it highlights that even with awareness programs in place, the goal of catching the disease early remains a challenge that needs more attention.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.